GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » EV-to-EBITDA

Lifeline Scientific (LSE:LSI) EV-to-EBITDA : 4.41 (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is Lifeline Scientific EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Lifeline Scientific's enterprise value is £26.67 Mil. Lifeline Scientific's EBITDA for the trailing twelve months (TTM) ended in Jun. 2016 was £6.04 Mil. Therefore, Lifeline Scientific's EV-to-EBITDA for today is 4.41.

The historical rank and industry rank for Lifeline Scientific's EV-to-EBITDA or its related term are showing as below:

LSE:LSI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.6   Med: 13.3   Max: 70.2
Current: 9.1

During the past 12 years, the highest EV-to-EBITDA of Lifeline Scientific was 70.20. The lowest was 2.60. And the median was 13.30.

LSE:LSI's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 16.29 vs LSE:LSI: 9.10

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Lifeline Scientific's stock price is £1.37. Lifeline Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2016 was £0.000. Therefore, Lifeline Scientific's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Lifeline Scientific EV-to-EBITDA Historical Data

The historical data trend for Lifeline Scientific's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific EV-to-EBITDA Chart

Lifeline Scientific Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.51 51.87 14.79 10.62 6.92

Lifeline Scientific Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 10.62 - 6.92 -

Competitive Comparison of Lifeline Scientific's EV-to-EBITDA

For the Medical Devices subindustry, Lifeline Scientific's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifeline Scientific's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeline Scientific's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lifeline Scientific's EV-to-EBITDA falls into.



Lifeline Scientific EV-to-EBITDA Calculation

Lifeline Scientific's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=26.666/6.044
=4.41

Lifeline Scientific's current Enterprise Value is £26.67 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lifeline Scientific's EBITDA for the trailing twelve months (TTM) ended in Jun. 2016 was £6.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifeline Scientific  (LSE:LSI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lifeline Scientific's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.37/0.000
=N/A

Lifeline Scientific's share price for today is £1.37.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lifeline Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2016 was £0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Lifeline Scientific EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifeline Scientific (LSE:LSI) Business Description

Traded in Other Exchanges
N/A
Address
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.